Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Intravenous Rituximab
DRUG
2 trials
Sponsors
Mayo Clinic
, Chulalongkorn University
Conditions
IgA Nephropathy
Recurrent IgA Nephropathy
Phase 4
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
Completed
NCT00498368
Mayo Clinic
IgA Nephropathy
Start: 2009-02-28
End: 2015-09-30
Updated: 2017-02-01
Rituximab in Recurrent IgA Nephropathy
NCT02571842
Chulalongkorn University
Recurrent IgA Nephropathy
Start: 2012-01-31
End: 2016-12-31
Target: 30
Updated: 2015-10-08
Related Papers
Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis.
2025-06-10
1 citations
Insights into the Role of Mucosal Immunity in IgA Nephropathy
Clinical Journal of the American Society of Nephrology
2018-07-31
31 citations